ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2025

Primary and Acquired Resistance to Immunotherapy with Checkpoint Inhibitors in NSCLC: From Bedside to Bench and Back.

Annapaola Mariniello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.